Acquisition - March 20, 2025
Xbrane in agreement to sell biosimilar candidate and parts of its organization to Alvotech
Xbrane Biopharma has entered into an agreement to sell XB003 (biosimilar candidate to Cimzia) and parts of its organization, including approximately 40 employees and laboratory equipment, to Alvotech for a total consideration of approximately SEK 275 million.
Acquisition - March 18, 2025
Paxman makes recommended takeover offer to Dignitana
Paxman has announced a recommended offer to the shareholders of Dignitana to transfer all shares issued by Dignitana to Paxman, against consideration in the form of a total of 2,476,207 newly issued shares in Paxman.
Acquisition - March 17, 2025
AstraZeneca to acquire EsoBiotec
EsoBiotec is a biotechnology company focusing on in vivo cell therapies that has demonstrated promising early clinical activity.
Acquisition - February 10, 2025
Pharming completes bid for Abliva
Pharming Technologies declares unconditional and completes the recommended cash offer to the shareholders of Abliva and extends the acceptance period.
Acquisition - February 10, 2025
Bain Capital acquires Mitsubishi Tanabe Pharma Corporation
Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group Corporation.
Acquisition - February 7, 2025
Asker Healthcare Group has acquired Mayumana Healthcare
Mayumana Healthcare is a specialist distributor of medical equipment and related supplies in the Netherlands.
